TI Best Evidence Webinar Shedding light on risks with anticholinergic drug use – Practical tips for patient care PRESENTER: Dr. Aaron M Tejani, PharmD. DATE: Wednesday, June 10, 2020 TIME: 12:00 - 13:00 (12:00 noon - 1:00 pm) Pacific Daylight Time (UTC/GMT -7hrs) [click here to convert to your local time] COST: FREE. Must register in order to attend. Everyone who registers will … [Read more...]
Communicating emerging risks of SGLT2 inhibitors—timeliness and transparency of medicine regulators
BMJ 2020; 369:m1107 (Published 29 April 2020) DOI: https://doi.org/10.1136/bmj.m1107 Key messages Sodium glucose co-transporter-2 (SGLT2) inhibitors came to market amid heightened concern over the safety of diabetes drugs The drugs have received several serious safety warnings since approval, but the number, timeliness, and strength of these safety communications have differed … [Read more...]
